BioNxt Solutions Inc. (CSE:BNXT)
Canada · Delayed Price · Currency is CAD 0.3900
0.00 (0.00%)
Jun 10, 2026, 2:39 PM EST
BioNxt Solutions Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | 0.03 | 0.37 | 0.3 | 0.29 | |
Revenue Growth (YoY) | - | - | -92.75% | 25.15% | 3.82% | -17.11% |
Cost of Revenue | - | - | - | - | 0.71 | 0.09 |
Gross Profit | - | - | 0.03 | 0.37 | -0.41 | 0.2 |
Selling, General & Admin | 3.22 | 3.2 | 2.41 | 3.36 | 3.7 | 8.97 |
Research & Development | 0.73 | 0.8 | 1.43 | 2.55 | 2.11 | 3.34 |
Operating Expenses | 6.88 | 5.93 | 4.48 | 6.73 | 6.16 | 16.41 |
Operating Income | -6.88 | -5.93 | -4.45 | -6.36 | -6.57 | -16.21 |
Interest Expense | -1.56 | -1.44 | -0.99 | -1.04 | -1.14 | -0.73 |
Interest & Investment Income | - | - | 0 | - | - | - |
Currency Exchange Gain (Loss) | 0.19 | 0.47 | 0.12 | 0.04 | 0.14 | -0.1 |
Other Non Operating Income (Expenses) | -0.11 | -0.11 | -0.11 | -0.03 | -0.1 | -0.1 |
EBT Excluding Unusual Items | -8.36 | -7.01 | -5.43 | -7.39 | -7.67 | -17.14 |
Gain (Loss) on Sale of Assets | 0.01 | -0.05 | - | -0.05 | - | - |
Asset Writedown | - | - | - | -0.05 | -5.89 | -3.68 |
Other Unusual Items | -1.14 | -0.17 | 0.03 | -0.24 | 0.69 | 0.07 |
Pretax Income | -9.49 | -7.22 | -5.4 | -7.72 | -12.87 | -20.75 |
Income Tax Expense | -0.2 | -0.2 | -0.09 | - | -0.49 | -0.11 |
Net Income | -9.3 | -7.03 | -5.31 | -7.72 | -12.38 | -20.64 |
Net Income to Common | -9.3 | -7.03 | -5.31 | -7.72 | -12.38 | -20.64 |
Shares Outstanding (Basic) | 121 | 118 | 111 | 99 | 84 | 70 |
Shares Outstanding (Diluted) | 121 | 118 | 111 | 99 | 84 | 70 |
Shares Change (YoY) | 6.73% | 6.04% | 12.17% | 18.56% | 19.28% | 22.75% |
EPS (Basic) | -0.08 | -0.06 | -0.05 | -0.08 | -0.15 | -0.29 |
EPS (Diluted) | -0.08 | -0.06 | -0.05 | -0.08 | -0.15 | -0.29 |
Free Cash Flow | -4.47 | -5.2 | -3.03 | -5.37 | -6.23 | -12.61 |
Free Cash Flow Per Share | -0.04 | -0.04 | -0.03 | -0.05 | -0.07 | -0.18 |
Gross Margin | - | - | 100.00% | 100.00% | -138.28% | 69.63% |
Operating Margin | - | - | -16502.86% | -1708.42% | -2210.02% | -5659.36% |
Profit Margin | - | - | -19683.18% | -2074.68% | -4160.84% | -7203.23% |
Free Cash Flow Margin | - | - | -11243.72% | -1442.32% | -2095.73% | -4400.52% |
EBITDA | -6.89 | -5.92 | -4.36 | -6.19 | -6.4 | -16.03 |
D&A For EBITDA | -0.01 | 0.01 | 0.09 | 0.16 | 0.17 | 0.18 |
EBIT | -6.88 | -5.93 | -4.45 | -6.36 | -6.57 | -16.21 |